Chart validation of inpatient ICD-9-CM administrative diagnosis codes for ischemic stroke among IGIV users in the Sentinel Distributed Database
- PMID: 29384925
- PMCID: PMC6392785
- DOI: 10.1097/MD.0000000000009440
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for ischemic stroke among IGIV users in the Sentinel Distributed Database
Abstract
The Sentinel Distributed Database (SDD) is a large database of patient-level medical and prescription records, primarily derived from insurance claims and electronic health records, and is sponsored by the U.S. Food and Drug Administration for drug safety assessments. In this chart validation study, we report on the positive predictive value (PPV) of inpatient ICD-9-CM acute ischemic stroke (AIS) administrative diagnosis codes (433.x1, 434.xx, and 436) in the SDD.As part of an assessment of the risk of thromboembolic adverse events following treatment with intravenous immune globulin (IGIV), charts were obtained for 131 potential post-IGIV AIS cases. Charts were abstracted by trained nurses and then adjudicated by stroke experts using pre-specified diagnostic criteria.Case status could be determined for 128 potential AIS cases, of which 34 were confirmed. The PPVs for the inpatient AIS diagnoses recorded in the SDD were 27% overall [95% confidence interval (95% CI): 19-35], 60% (95% CI: 32-84) for principal-position diagnoses, 42% (95% CI: 28-57) for secondary diagnoses, and 6% (95% CI: 2-15) for position-unspecified diagnoses (which in the SDD generally originate from separate physician claims associated with an inpatient stay).Position-unspecified diagnoses were unlikely to represent true AIS cases. PPVs for principal and secondary inpatient diagnosis codes were higher, but still meaningfully lower than estimates from prior chart validation studies. The low PPVs may be specific to the IGIV user study population. Additional research is needed to assess the validity of AIS administrative diagnosis codes in other study populations within the SDD.
Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
EMA is now an employee in the Medical Device Epidemiology division at Johnson & Johnson. The analyses for this paper were completed and the manuscript drafted prior to his start in that role. The other authors report no conflicts.
Figures

Similar articles
-
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):398-404. doi: 10.1002/pds.4398. Epub 2018 Feb 15. Pharmacoepidemiol Drug Saf. 2018. PMID: 29446185 Free PMC article.
-
Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.Medicine (Baltimore). 2018 Feb;97(8):e9960. doi: 10.1097/MD.0000000000009960. Medicine (Baltimore). 2018. PMID: 29465588 Free PMC article.
-
Medical chart validation of inpatient diagnosis codes for transfusion-related acute lung injury 2013-2015.Transfusion. 2021 Mar;61(3):754-766. doi: 10.1111/trf.16251. Epub 2021 Jan 27. Transfusion. 2021. PMID: 33506519 Free PMC article.
-
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.PLoS One. 2015 Aug 20;10(8):e0135834. doi: 10.1371/journal.pone.0135834. eCollection 2015. PLoS One. 2015. PMID: 26292280 Free PMC article.
-
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review.Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):795-811. doi: 10.1002/pds.5608. Epub 2023 Mar 27. Pharmacoepidemiol Drug Saf. 2023. PMID: 36890603 Review.
Cited by
-
Electronic Medical Record-Based Case Phenotyping for the Charlson Conditions: Scoping Review.JMIR Med Inform. 2021 Feb 1;9(2):e23934. doi: 10.2196/23934. JMIR Med Inform. 2021. PMID: 33522976 Free PMC article.
-
A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Pharmacoepidemiol Drug Saf. 2025 Mar;34(3):e70124. doi: 10.1002/pds.70124. Pharmacoepidemiol Drug Saf. 2025. PMID: 40095398 Free PMC article.
-
Validation of Claims-Based Algorithm for Lyme Disease, Massachusetts, USA.Emerg Infect Dis. 2023 Sep;29(9):1772-1779. doi: 10.3201/eid2909.221931. Emerg Infect Dis. 2023. PMID: 37610117 Free PMC article.
-
A scoping review of the methodological approaches used in retrospective chart reviews to validate adverse event rates in administrative data.Int J Qual Health Care. 2024 May 10;36(2):mzae037. doi: 10.1093/intqhc/mzae037. Int J Qual Health Care. 2024. PMID: 38662407 Free PMC article.
-
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.Am Heart J. 2019 Jun;212:64-71. doi: 10.1016/j.ahj.2019.02.007. Epub 2019 Mar 6. Am Heart J. 2019. PMID: 30953936 Free PMC article.
References
-
- Snapshot of Database Statistics. Sentinel Coordinating Center, 2017. Available at: https://www.sentinelinitiative.org/sentinel/snapshot-database-statistics. Accessed September 10, 2017.
-
- ICD-9-CM Coding Guidelines: DRG 014—Intracranial Hemorrhage or Cerebral Infarction, DRG 559—Acute Ischemic Stroke with Use of Thrombolytic Agent. Primaris, 2006. Available at: http://www.primaris.org/sites/default/files/resources/HPMP/coding%20guid.... Accessed January 22, 2016.
-
- The Mini-Sentinel Thromboembolic Events after Immunoglobulin Administration Workgroup. Mini-Sentinel Assessment Protocol: Thromboembolic Events After Immunoglobulin Administration: Version 3.0. Mini-Sentinel Coordinating Center, 2015. Available at: https://www.sentinelinitiative.org/sites/default/files/Drugs/Assessments.... Accessed September 10, 2017.
-
- Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117:S525–53. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical